Free Newsletter
SPOTLIGHT: Hikal wins Pfizer manufacturing deal
Free newsletter via e-mail
Tools
An Indian contract manufacturing company is jumping for joy after Pfizer chose it as a supplier of active pharmaceutical ingredients. Hikal will make the APIs at its FDA-approved manufacturing plant in Bangalore. Interestingly, the Indian company had been considering a buyout of Pfizer's Ireland operations, but dropped out of the bidding. Release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: